Form D · Hedge Fund

HighVista Biotechnology Opportunities Fund LP

Boston, MA · CIK 0001816829

Offering snapshot reported Jul 6, 2026 · SEC filing

Reported sold
$453M
Indefinite offering
Investors reported
55
Form D · investor count
Minimum accepted
$500K
Reported outside-investor minimum
First sale
Jul 1, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$227M$453MApr 12, 2021: $200,600,000.00Apr 12, 2021Jul 15, 2022: $358,427,023.00Jul 15, 2022Jul 13, 2023: $377,327,023.00Jul 13, 2023Jul 12, 2024: $396,533,540.00Jul 12, 2024Jul 11, 2025: $434,868,951.00Jul 11, 2025Jul 6, 2026: $453,188,582.00Jul 6, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$434,868,951 → $453,188,582
  • Reported investors50 → 55

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 6, 2026Amendment$453,188,582$18,319,631vs Jul 11, 202555SEC filing
Jul 11, 2025Amendment$434,868,951$38,335,411vs Jul 12, 202450SEC filing
Jul 12, 2024Amendment$396,533,540$19,206,517vs Jul 13, 202334SEC filing
Jul 13, 2023Amendment$377,327,023$176,727,023vs Apr 12, 202130SEC filing
Jul 15, 2022Amendment$358,427,023$157,827,023vs Apr 12, 202128SEC filing
Jul 15, 2021Amendment$200,600,000No comparisonNot reportedSEC filing
Apr 12, 2021Amendment$200,600,000No comparisonNot reportedSEC filing
Jan 14, 2021Amendment$192,400,000$44,900,000vs Jul 16, 202018SEC filing
Jul 16, 2020Initial$147,500,000No comparison12SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-371199

Source: Form D, filed Jul 6, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

HIGHVISTA BIOTECHNOLOGY OPPORTUNITIES FUND LP

Investment adviser: HIGHVISTA STRATEGIES LLC

Gross asset value
$378M
Beneficial owners
44
ADV minimum commitment
$5M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CITCO FUND ADMINISTRATION (CAYMAN ISLANDS) LIMITED GRAND CAYMAN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor PRICEWATERHOUSE COOPER LLP BOSTON, Massachusetts, United States
Custodian CITCO BANKING CORPORATION N.V. WILLEMSTAD, Curacao Related to adviser: No
Custodian J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian NORTHERN TRUST INTERNATIONAL BANKING CORPORATION JERSEY CITY, New Jersey, United States Related to adviser: No
Prime broker J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

PRICEWATERHOUSE COOPER LLP
PCAOB 238

CITCO BANKING CORPORATION N.V.
LEI 549300HEYP0HGEVT8L46

J.P. MORGAN SECURITIES LLC
SEC 8-35008

NORTHERN TRUST INTERNATIONAL BANKING CORPORATION
LEI 54930042DBMRRWU1QM80

J.P. MORGAN SECURITIES LLC
CRD 79 · SEC 8-35008

Filing source

Form ADV 2055416 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-8040975429

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A High Vista Gp Vii Limited Partnership Executive
N/A High Vista Strategies Llc Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Highvista Strategies Llc 200 Clarendon Street, 50 Th Floor
Boston, MA, 02116